VEGF is thus involved in the pathogenesis of endometriosis and the inhibition of VEGF and/or its receptor may be a potential therapeutic target for the treatment of endometriosis as investigated in various animal models [45], [48]–[50]. The gene discussed is VEGFA; the disease is endometriosis.